Aspen Aerogels Q2 net loss narrows to $15.4M; gross margin hits 17%, guidance improved

ASPEN AEROGELS INC

2023-Q2 EPS reported -$0.47 revenue$93,744,000

Revenue $48.2M, up from $45.6M YoY; net loss $15.4M vs $24.1M YoY; EPS -$0.22 vs -$0.68.
Gross margin 17%, a 20-percentage point improvement vs prior year.
Adjusted EBITDA loss $(10.8)M vs $(18.3)M YoY.
Reduced 2023 net loss outlook by $17M; expects strong H2 demand growth.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ASPEN AEROGELS INC reported second quarter of 2023 results: revenue $48.2 million, net income $15.4 million, EPS $0.22. Guidance lowered.

Period: second quarter of 2023
Revenue: $48.2 million
Net income: $15.4 million
EPS: $0.22
Guidance: lowered
Result: reported results

Exact text from the filing

Total revenue for the second quarter of 2023 was $48.2 million, compared to $45.6 million in the second quarter of last year. Net loss was $15.4 million, compared to a net loss of $24.1 million in the second quarter of last year. Net loss per share was $0.22, compared to a net loss per share of $0.68 in the second quarter last year.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

ASPEN AEROGELS INC filing history →

Source: SEC EDGAR

accession 0000950170-23-037235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.